Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension

Journal of Human Hypertension

Volumn 28, Issue 2, 2014, Pages 133-139

  Sykes, S D ^a,b   Pringle, K G ^a   Zhou, A ^b   Dekker, G A ^b,c   Roberts, C T ^b   Lumbers, E R ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c LYELL MCEWIN HOSPITAL   (Australia)

Author keywords

Angiotensin II; Angiotensin (1 7); Angiotensin converting enzyme; Gestational hypertension; Preeclampsia; Prorenin

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; PRORENIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

ADULT; ANGIOTENSIN I; ANGIOTENSIN II; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PRE-ECLAMPSIA; PREGNANCY; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; RISK FACTORS; SEX DETERMINATION ANALYSIS; SEX FACTORS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84891891170     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.51     Document Type: Article

References (40)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367(9516): 1066-1074.
2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33(3): 130-137.
3. Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998; 16(6): 853-862.
4. Gilbert JS, Nijland MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol 2008; 295(6): R1941-R1952.
5. Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991; 40(4-6): 511-515.
6. Clauser E, Gaillard I, Wei L, Corvol P. Regulation of angiotensinogen gene. Am JHypertens 1989; 2(5 Pt 1): 403-410.
7. Sykes SD, Pringle KG, Zhou A, Dekker GA, Roberts CT, Lumbers ER. The balance between human maternal plasma angiotensin II and angiotensin 1-7 levels in early gestation pregnancy is influenced by fetal sex. J Renin Angiotensin Aldosterone Syst 2013 (e-pub ahead of print, 27 February 2013; doi:2010.1177/ 1470320313477174).
8. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012; 2(2): 72-83.
9. Anton L, Merrill DC, Neves LA, Gruver C, Moorefield C, Brosnihan KB. Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study. Reprod Biol Endocrinol 2010; 8: 135.
10. North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342: d1875.
11. Hanssens M, Keirse MJ, Spitz B, van Assche FA. Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynaecol 1991; 98(2): 155-161.
12. Nogueira AI, Souza Santos RA, Simoes ESAC, Cabral AC, Vieira RL, Drumond TC et al. The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes. Regul Pept 2007; 141(1-3): 55-60.
13. Baker PN, Broughton Pipkin F, Symonds EM. Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond) 1990; 79(4): 403-408.
14. Langer B, Grima M, Coquard C, Bader AM, Schlaeder G, Imbs JL. Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet Gynecol 1998; 91(2): 196-202.
15. Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002; 18(3): 239-245.
16. Symonds EM, Broughton Pipkin F, Craven DJ. Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol 1975; 82(8): 643-650.
17. Velloso EP, Vieira R, Cabral AC, Kalapothakis E, Santos RA. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype. Braz J Med Biol Res 2007; 40(4): 583-590.
18. Marques FZ, Pringle KG, Conquest A, Hirst JJ, Markus MA, Sarris M et al. Molecular characterization of renin-angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section. Placenta 2011; 32(3): 214-221.
19. Pringle KG, Tadros MA, Callister RJ, Lumbers ER. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta 2011; 32(12): 956-962.
20. Valdes G, Neves LA, Anton L, Corthorn J, Chacon C, Germain AM et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 2006; 27(2-3): 200-207.
21. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93(10): 1049-1059.
22. Simmons LA, Hennessy A, Gillin AG, Jeremy RW. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. BJOG 2000; 107(5): 678-685.
23. Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 2012; 87(2): 36.
24. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103(7): 945-952.
25. Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 2010; 55(2): 386-393.
26. Dechend R, Muller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J et al. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev 2005; 4(1): 61-65.
27. Kooner JS, May CN, Peart S, Mathias CJ. Separation of peripheral and central cardiovascular actions of angiotensin II. Am J Physiol 1997; 273(6 Pt 2): H2620-H2626.
28. Smookler HH, Severs WB, Kinnard WJ, Buckley JP. Centrally mediated cardiovascular effects of angiotensin II. J Pharmacol Exp Ther 1966; 153(3): 485-494.
29. Heitsch H, Brovkovych S, Malinski T, Wiemer G. Angiotensin-(1-7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001; 37(1): 72-76.
30. Silvestre JS, Levy BI. [The renin-angiotensin system and post-ischemic angiogenesis]. Bull Acad Natl Med 2004; 188(4): 649-659, discussion 659.
31. Carbajo-Lozoya J, Lutz S, Feng Y, Kroll J, Hammes HP, Wieland T. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cell Signal 2012; 24(6): 1261-1269.
32. Machado RD, Santos RA, Andrade SP. Mechanisms of angiotensin-(1-7)- induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol 2001; 280(4): R994-R1000.
33. Anton L, Merrill DC, Neves LA, Brosnihan KB. Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 2007; 32(2): 212-218.
34. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009; 8(6): 1676-1683.
35. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277(17): 14838-14843.
36. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12(6): 642-649.
37. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obst Gynecol 2004; 191(4): 1240-1246.
38. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290(22): 2945-2951.
39. Jasovic-Siveska E, Jasovic V. Prediction of mild and severe preeclampsia with blood pressure measurements in first and second trimester of pregnancy. Ginekol Pol 2011; 82(11): 845-850.
40. Piquilloud Y, Reinharz A, Roth M. Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta 1970; 206(1): 136-142.